# Bicycle Therapeutics Q3 Revenue Climbs 190.4% to $34.06 Million

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/43584
Published: 2026-10-29T14:02:09.000Z
Updated: 2026-10-29T14:02:09.000Z
Section: Business

> GAAP EPS was a loss of $0.15, $0.33 above estimates. Revenue exceeded estimates by $21.86 million.

Bicycle Therapeutics plc (NASDAQ: BCYC) posted third-quarter revenue of $34.06 million, up 190.4% year over year, while its GAAP loss per share was narrower than analysts expected.

Revenue exceeded estimates by $21.86 million. GAAP earnings per share were a loss of $0.15, beating estimates by $0.33.